Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
‘Hustle’ and a heart: Beth Engel on the ethos of Dundee Venture Capital’s new fund
In a red, grid-lined journal, Beth Engel outlines a note in large block letters. With each stroke of her pen, “HUSTLE” grows bolder. As though to protect the musing, the venture capitalist of three years adds a box around the reminder before once again tracing over the word. Engel continues to sketch as she eloquently…
Timely funding opportunities for Kansas City startups
Despite Kansas City’s recognition as a tech hub, its variety of incubator programs and array of successful startup ventures, the metro’s entrepreneurial ecosystem is still trying to fill the money gap. How can the community ensure that entrepreneurs have access the capital they need? Well, as KCSourceLink knows well, appropriate funding resources vary widely depending…
Mobility Designed tackles a demand unaddressed since the Civil War
Editor’s note: This content is sponsored by LaunchKC but independently produced by Startland News. Some technologies are slow to innovate. And crutches — which haven’t changed much since the U.S. Civil War — are a prime example. “They’ve pretty much been the same for decades,” said Liliana Younger, CEO of Mobility Designed. “Although there…
Two area startups still vying for $25K from the Kauffman Foundation
The Ewing Marion Kauffman Foundation on Monday announced the top 15 finalists in the 1 in a Million pitch competition that are vying for a $25,000 grant — and two startups hail from the metro area. Kansas City-based The Grooming Project and Lawrence-based DraftPak both cracked the top 15 in the contest after beating out…